If your feed has started promising that one hormone will fix your sleep, your energy and your sex drive, you are not imagining the trend. Menopause researchers are worried about what is getting lost inside the enthusiasm.
CBC News examined the growing use of testosterone among women managing menopause symptoms, and the distance between what influencers promise and what the published evidence supports is worth understanding before anybody books an appointment or opens a wallet. The short version of it runs something like this. Testosterone for menopause is not an approved treatment in either Canada or the United States, off-label use is climbing anyway, and regulators have now begun asking drug makers for research designed specifically around women.
Key takeaways
Testosterone is not approved to treat menopause symptoms in Canada or the United States, and current use in women is off-label.
The United States Food and Drug Administration held a public workshop on testosterone use in menopausal women on Sept. 17, 2026, and called for women-specific research.
Most existing research on testosterone in women focuses narrowly on post-menopausal women with hypoactive sexual desire disorder rather than on menopause symptoms generally.
Testosterone in women declines gradually with age rather than dropping sharply at menopause, which is the opposite of the pattern seen with estrogen and progesterone.
Researchers cite limited long-term safety data in women, effects of oral formulations on cholesterol, and side effects including unwanted hair growth and oily skin.
Approved and evidence-backed hormone therapies for menopause symptoms do exist and have become more accessible over the past few years.
Why Is Your Feed Suddenly Full Of This Hormone?
The reason your feed is suddenly full of one hormone is that a genuine shift in menopause care has created an opening that marketing moved into faster than the evidence did. The people selling testosterone for menopause online did not invent that shift, and they are right that the mood around hormone therapy has changed. Hormone therapy in general is returning to mainstream practice after two decades of decline that followed a large American clinical trial published in 2002, which appeared at the time to show that the risks of combined estrogen and progesterone therapy outweighed the benefits.
Later analysis identified methodological problems with that trial, which had studied an older, largely post-menopausal population, but the fear it generated outlasted the criticism by many years. More recently, American regulators endorsed estrogen and progesterone for menopause symptoms as safe and effective and removed longstanding boxed warnings from those products. That reversal was welcome news for women who had been refused treatment for years, and it also created a receptive audience for claims that ran well ahead of any published data.
Something similar happened with hormonal contraception coverage in Canada, where a single study reshaped public conversation faster than clinicians could contextualize it, which we covered in our reporting on what the birth control and meningioma findings actually mean for Canadian patients.
What Does The Research Actually Show So Far?
The menopause researchers who spoke to CBC News were consistent with one another, and what the research actually shows is a good deal narrower than the marketing around it suggests. Jerrilyn Prior, a professor emerita of endocrinology at the University of British Columbia, explained that testosterone is produced at lower levels in women than in men and declines gradually with age, typically well before menopause arrives, which is a different pattern from the sharp drop seen in estrogen and progesterone.
That distinction matters because the argument for supplementation rests on the idea that menopause causes a deficiency requiring correction. Research published this year in a large cross-sectional study of women at midlife found that testosterone concentrations declined from around age 40 and were not meaningfully affected by the natural menopause transition itself, and the authors concluded that their data do not support menopause on its own as an indication for testosterone supplementation.
Most of the research that does exist focuses specifically on post-menopausal women with hypoactive sexual desire disorder, meaning low desire that causes the person genuine personal distress. That is a defined clinical condition rather than a general description of how somebody feels during perimenopause, and it is the only indication for which international guidelines currently support testosterone in women. Most claims about testosterone for menopause step straight across that distinction without ever naming it.
Researchers also raised safety concerns that rarely appear in a 30-second video. The data on mood, cognition and general well-being in women remains thin, long-term safety evidence is scarce, oral formulations carry unfavourable effects on cholesterol, and the side effects include hair growth in unwanted places and oily skin that people find disruptive enough to stop treatment over.
Which Symptoms Have Other Causes Worth Checking?
One of the more practical warnings from clinicians is that attributing every symptom to perimenopause can delay the diagnosis of something entirely separate. Many symptoms have other causes that deserve screening on their own terms, and bodies continue to change with age in ways that have nothing to do with reproductive hormones.
Fatigue is the clearest example, because it overlaps with thyroid disease, anemia, sleep apnea, depression and medication side effects, and our explainer on why you feel so tired after eating covers several of the everyday mechanisms that get misread as hormonal. Joint pain is another, and the age-related changes behind it are set out in our piece on why your knees and hips hurt more than they used to.
Low desire itself frequently has causes beyond hormones, including other medical conditions, medication side effects, mood, body image and ordinary life stress, any of which can be addressed directly once somebody has actually looked for them.
What Should You Expect At A Full Health Assessment?
The recommendation researchers keep returning to is straightforward, which is to get assessed properly rather than to self-diagnose from social media. A full health assessment at this stage of life usually runs longer than a standard appointment, so it is worth booking accordingly and saying why when you book.
Expect a conversation covering your symptoms and their timeline, your menstrual history, your sleep, your mood, your medications and your family history. Expect blood work that may include thyroid function, iron studies and a lipid panel. Expect a discussion of bone health, because bone density falls faster in the years around menopause, and our guide on what a bone density test involves in Canada explains when screening is usually recommended.
Expect, too, a conversation about muscle mass and strength, which decline with age and respond well to deliberate training, as covered in our guide on how to rebuild muscle loss in older adults. None of this rules out hormone therapy as an option for you. It simply establishes what you are actually treating before anybody starts treating it.
What Are The Steps To Take Before You Book Anything?
The steps to take before you spend money are cheap, quick, and considerably more useful than another hour of scrolling.
Write down your three most disruptive symptoms with rough start dates, since a timeline tells a clinician far more than a general description of feeling unwell.
List every medication and supplement you currently take, because several common ones produce symptoms routinely attributed to perimenopause.
Book a longer appointment and say when you book that you want a full assessment rather than a single-issue visit.
Ask specifically which treatments are approved for your symptoms in Canada and what the evidence behind each one looks like.
Check the cost and the credentials before paying for any private hormone program, and ask what monitoring is included.
Bring anything you saw online to the appointment and ask directly what the evidence says for somebody with your history.
Frequently asked questions
Is This Hormone Approved For Women In Canada?
No product is approved in Canada or the United States with a specific indication for treating menopause symptoms in women. Current use relies on products approved for men, prescribed off-label, or on compounded preparations. Regulators in the United States began formally examining the question in Sept. 2026 and asked drug makers to conduct research designed around women.
What Side Effects Do Researchers Warn About Most?
The most commonly reported effects are hair growth in unwanted places and oily skin, both of which people find disruptive enough to stop treatment. Oral formulations also carry unfavourable effects on cholesterol levels. Researchers point to a shortage of long-term safety data in women, which means the risks over many years of use remain genuinely uncertain rather than reassuringly small.
Does This Hormone Actually Drop At Menopause?
Not in the way that estrogen and progesterone do at the menopause transition. Levels in women decline gradually from around age 40 rather than falling sharply at the menopause transition. Research published this year found no meaningful effect of natural menopause on concentrations, and the authors concluded that menopause on its own does not support supplementation as an indication.
What Hormone Therapy Is Actually Approved For Symptoms?
Menopausal hormone therapy using estrogen, with progesterone where the uterus is intact, is approved and is described in guidelines as the most effective option for symptoms such as hot flashes in most women under 60 or within 10 years of menopause. Suitability turns on your personal and family medical history, and establishing that is exactly what the assessment is for.
How Do You Raise This Properly With A Doctor?
Book a longer appointment, bring a written symptom timeline with start dates, and list your medications and supplements. Say plainly that you want a full assessment rather than a single-issue visit. If you have seen a specific claim online, bring it and ask what the evidence says for somebody with your history rather than for women in general.
What Is Your Next Step From Here?
Your next step is an appointment with somebody who can look at your whole picture rather than a checkout page. Medimap can help you find a family practice clinic near you, book a walk-in or virtual visit with wait times you can see first, or locate a pharmacy for a medication review. For more evidence-first coverage of the conditions people are being sold solutions for, visit the Medimap Health Hub.
Disclaimer: This article is for general information and is not medical advice, a diagnosis, or a substitute for care from a qualified health professional. Medimap does not prescribe medication or provide treatment. Decisions about hormone therapy belong with a prescriber who knows your history. If you are experiencing a medical emergency, call 911 or go to your nearest emergency department.
Find an allergy or specialist clinic near you? Search through Medimap — no referral needed.
Search clinics →
